跳到正文
FDA 官方药品与生物制品信息·AI 评分32

FDA 发布 GDUFA Type II API DMF 缴费收据报告

GDUFA Type II API DMF Payment Receipts Report

AI 导读

FDA 发布 GDUFA Type II 原料药 DMF 缴费收据报告,按收到月份和财年汇总月度缴费笔数。报告显示 FY 2023 至 FY 2026 合计分别为 385、263、370 和 303 笔,并注明数字可能因退款或其他缴费问题变动。

正文 · 原文

The DMF Payments Received table summarizes total monthly counts of GDUFA Type II Active Pharmaceutical Ingredient (API) Drug Master File (DMF) payments according to the month and the fiscal year in which they were received by the Agency. The numbers are subject to change due to refunds or other payment issues.

DMF Payments Received
 

MonthFY 2023FY 2024FY 2025FY 2026
Oct14827-
Nov21212222
Dec32283229
Jan33283022
Feb28242017
Mar31243230
Apr17163127
May22142615
June15141527
July27333439
Aug42292119
Sept103248054
Grand Total385263370303

来源:FDA 官方药品与生物制品信息 · fda.gov